Forwarded from PDFology (Basem Medhat)
تلخيصات طبية
Which antidepressant drug must be avoided in a 21 year-old female with a history of seizure disorder?
Forwarded from أجيج
كلّ يومٍ هناك فرصة جيدة ومساحة واسعة لعُمران الجَنّةِ مِن هُنا، إن صَدَقنا القَصد، وأحسَنّا الخُطىٰ، وأخلَصنا السِّرّ للّه..
-قصي عاصم.
لا تنسوا الصلاة على النبي والكهف والدعاء،
ولا تنسونا..
-قصي عاصم.
لا تنسوا الصلاة على النبي والكهف والدعاء،
ولا تنسونا..
Forwarded from PDFology (Basem Medhat)
سورة الكهف.pdf
3.7 MB
قال أبي سعيد الخدري رضي الله عنه: قال رسول الله صلى الله عليه وسلم: من قرأ سورة الكهف في يوم الجمعة، أضاء له من النور ما بين الجمعتين. رواه الحاكم والبيهقي وصححه الألباني.
﴿ إِنَّ اللَّهَ وَمَلَائِكَتَهُ يُصَلُّونَ عَلَى النَّبِيِّ ۚ يَا أَيُّهَا الَّذِينَ آمَنُوا صَلُّوا عَلَيْهِ وَسَلِّمُوا تَسْلِيمًا﴾
[ الأحزاب: 56]
﴿ إِنَّ اللَّهَ وَمَلَائِكَتَهُ يُصَلُّونَ عَلَى النَّبِيِّ ۚ يَا أَيُّهَا الَّذِينَ آمَنُوا صَلُّوا عَلَيْهِ وَسَلِّمُوا تَسْلِيمًا﴾
[ الأحزاب: 56]
Forwarded from PDFology (Basem Medhat)
Epilepsy (partII).pdf
9.8 MB
تفريغ د عبد المتعال فودة CNS
Therapy of epilepsy
Part2: 1st generation of antiepileptic drugs
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
⚠️⚠️ملاحظة: واجهة صورة الpdf مكتوب بيها part3: 2nd generation سهواً انما هيه part2: 1st generation اتمنى الانتباه وشكراً💙💙
#Pharmacy
#Neurology
#Tafreghat
#غزة 🇵🇸
Therapy of epilepsy
Part2: 1st generation of antiepileptic drugs
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
⚠️⚠️ملاحظة: واجهة صورة الpdf مكتوب بيها part3: 2nd generation سهواً انما هيه part2: 1st generation اتمنى الانتباه وشكراً💙💙
#Pharmacy
#Neurology
#Tafreghat
#غزة 🇵🇸
Forwarded from Reda Harby
Forwarded from Reda Harby
Forwarded from Coursemia
🫁Lung Volumes by Reda Harby ❤️
Like never before 👏
Full Free Session: 🏆
https://redaharbycourses.com/lung-volumes-diseases/
Like never before 👏
Full Free Session: 🏆
https://redaharbycourses.com/lung-volumes-diseases/
Forwarded from PDFology (Basem Medhat)
تلخيصات طبية
Photo
إيه دور Empagliflozin في علاج مرضى CKD؟
🌟 Empagliflozin: A Potential Therapeutic Option for Chronic Kidney Disease (CKD)
Recent clinical trials have shed light on the potential benefits of empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, for patients with chronic kidney disease (CKD).
🔍 Emerging Evidence: The EMPA-KIDNEY trial demonstrated that empagliflozin therapy, compared to placebo, may significantly reduce the risk of a composite endpoint of kidney disease progression (including end-stage renal disease or sustained eGFR decline) or cardiovascular death in a broad population of CKD patients.
🔬 Mechanism of Action: Empagliflozin primarily functions by lowering blood sugar levels by promoting urinary sugar excretion. However, in CKD, it may also offer renoprotective effects by reducing intraglomerular pressure and inflammation.
💊 Potential Benefits: Clinical data suggests empagliflozin may slow CKD progression, decrease the need for dialysis, and reduce the risk of cardiovascular complications in some patients.
Additionally, research indicates a potential for decreased overall hospitalization rates.
📋 Individualized Treatment Considerations: It's important to note that empagliflozin is not universally recommended for all CKD patients.
Comorbidities, kidney function stage, and other medications should be considered when evaluating a patient's suitability for this therapy.
🔍 In Conclusion: Empagliflozin represents a promising therapeutic approach for specific CKD patient populations.
However, further research is needed to fully define its role in CKD management.
🌐 Reference ➡️ Pubmed
#PDFology
#غزة 🇵🇸
🌟 Empagliflozin: A Potential Therapeutic Option for Chronic Kidney Disease (CKD)
Recent clinical trials have shed light on the potential benefits of empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, for patients with chronic kidney disease (CKD).
🔍 Emerging Evidence: The EMPA-KIDNEY trial demonstrated that empagliflozin therapy, compared to placebo, may significantly reduce the risk of a composite endpoint of kidney disease progression (including end-stage renal disease or sustained eGFR decline) or cardiovascular death in a broad population of CKD patients.
🔬 Mechanism of Action: Empagliflozin primarily functions by lowering blood sugar levels by promoting urinary sugar excretion. However, in CKD, it may also offer renoprotective effects by reducing intraglomerular pressure and inflammation.
💊 Potential Benefits: Clinical data suggests empagliflozin may slow CKD progression, decrease the need for dialysis, and reduce the risk of cardiovascular complications in some patients.
Additionally, research indicates a potential for decreased overall hospitalization rates.
📋 Individualized Treatment Considerations: It's important to note that empagliflozin is not universally recommended for all CKD patients.
Comorbidities, kidney function stage, and other medications should be considered when evaluating a patient's suitability for this therapy.
🔍 In Conclusion: Empagliflozin represents a promising therapeutic approach for specific CKD patient populations.
However, further research is needed to fully define its role in CKD management.
🌐 Reference ➡️ Pubmed
#PDFology
#غزة 🇵🇸
Forwarded from PDFology (Basem Medhat)
Which one of the following medications is known to induce pulmonary toxicity?
Anonymous Quiz
53%
A. Amiodarone
12%
B. Metoprolol
23%
C. Carbamazepine
12%
D. Glibeniclamide
تجميعة سريعة لبعض البوستات المهمة
سواء تخص الجايدلاينز أو القنوات أو المعادلات الأجنبية:
.
مواقع الجايدلاينز:
الموقع ده تقريبا مجمع كل الجايدلاينز .. مجرد تبحث في خانة البحث من فوق
https://www.medscape.co.uk/primary-care-guidelines
.
دا نفس الحوار هتلاقي كل الجايدلاينز تقريبا عليه (مجرد فقط ابحث)
https://www.guidelinecentral.com/guidelines/?fbclid=IwZXh0bgNhZW0CMTAAAR0eDbaOrTuY5oJLRltZOBlKL02N-79gUzX_72uQ8RitSAdeT7rBizDUQL8_aem_AcnV1RpZTpqzx1ekuGxbf0b0-yr-CnsdsZN2bEq-xn-mjjIwRCMnktGPVUf2CPXZNhNG45y_POSf9ZOu8Ysw-d1j
.
مواقع الجايدلانز في تخصصات الباطنة
https://www.facebook.com/AAlskary/posts/pfbid04RfnZHUhYY4BxdPzW1z1SCeHhooyYYaEZkknbKjhFFzcGvZt9B8y92xtkcruPQ6dl
.
بعض مواقع الجايدلاينز لتخصص الأطفال:
https://www.facebook.com/AAlskary/posts/pfbid02ue6L1xSs4uSZjXkrex1h19WA764TMso9X71f2HYtRCSEuksepENnbCcbg7oxqpj8l
.
مصادر مذاكرة وقنوات للمتخصصين في القلب (والباطنة)
https://www.facebook.com/AAlskary/posts/pfbid023ic3idABCvkJzUsqR7VXDuVasNWBkep6JQ7iadJZ6cKnFayDyeay7TBhk1Z9mccGl
.
المعادلات MRCP & USMLE
https://www.facebook.com/AAlskary/posts/pfbid02j74afGLvgVMGgFBpzkntwUgUo58fGCTcY7gNmnWtJAFRvg2X1E9Hm4P9xHcA3g37l
.
https://www.facebook.com/AAlskary/posts/pfbid07P28BGf69xjAtwkerUPzhzqP3aqjBgGRTXB7gWxGNpEHALW14YobNhoYuCgVRV1Jl
.
القنوات:
.
https://www.facebook.com/AAlskary/posts/pfbid02CM7d7T7Hvd4HzRi2CrNhdyaZaAqDdLjxhcwxfNNCXGrz3kuCyPSQxqHnT3dQaXTgl
.
https://www.facebook.com/permalink.php?story_fbid=pfbid0ohKMyMeXe38pV7Ty3Ts1sKQiUHANaG32TXUy7LU4ahdyis9L3wegff3C4ByXaTtSl&id=100027854642044
سواء تخص الجايدلاينز أو القنوات أو المعادلات الأجنبية:
.
مواقع الجايدلاينز:
الموقع ده تقريبا مجمع كل الجايدلاينز .. مجرد تبحث في خانة البحث من فوق
https://www.medscape.co.uk/primary-care-guidelines
.
دا نفس الحوار هتلاقي كل الجايدلاينز تقريبا عليه (مجرد فقط ابحث)
https://www.guidelinecentral.com/guidelines/?fbclid=IwZXh0bgNhZW0CMTAAAR0eDbaOrTuY5oJLRltZOBlKL02N-79gUzX_72uQ8RitSAdeT7rBizDUQL8_aem_AcnV1RpZTpqzx1ekuGxbf0b0-yr-CnsdsZN2bEq-xn-mjjIwRCMnktGPVUf2CPXZNhNG45y_POSf9ZOu8Ysw-d1j
.
مواقع الجايدلانز في تخصصات الباطنة
https://www.facebook.com/AAlskary/posts/pfbid04RfnZHUhYY4BxdPzW1z1SCeHhooyYYaEZkknbKjhFFzcGvZt9B8y92xtkcruPQ6dl
.
بعض مواقع الجايدلاينز لتخصص الأطفال:
https://www.facebook.com/AAlskary/posts/pfbid02ue6L1xSs4uSZjXkrex1h19WA764TMso9X71f2HYtRCSEuksepENnbCcbg7oxqpj8l
.
مصادر مذاكرة وقنوات للمتخصصين في القلب (والباطنة)
https://www.facebook.com/AAlskary/posts/pfbid023ic3idABCvkJzUsqR7VXDuVasNWBkep6JQ7iadJZ6cKnFayDyeay7TBhk1Z9mccGl
.
المعادلات MRCP & USMLE
https://www.facebook.com/AAlskary/posts/pfbid02j74afGLvgVMGgFBpzkntwUgUo58fGCTcY7gNmnWtJAFRvg2X1E9Hm4P9xHcA3g37l
.
https://www.facebook.com/AAlskary/posts/pfbid07P28BGf69xjAtwkerUPzhzqP3aqjBgGRTXB7gWxGNpEHALW14YobNhoYuCgVRV1Jl
.
القنوات:
.
https://www.facebook.com/AAlskary/posts/pfbid02CM7d7T7Hvd4HzRi2CrNhdyaZaAqDdLjxhcwxfNNCXGrz3kuCyPSQxqHnT3dQaXTgl
.
https://www.facebook.com/permalink.php?story_fbid=pfbid0ohKMyMeXe38pV7Ty3Ts1sKQiUHANaG32TXUy7LU4ahdyis9L3wegff3C4ByXaTtSl&id=100027854642044
www.medscape.co.uk
Primary Care Clinical Guidelines | Medscape UK
Get summaries of clinical guidelines on diseases and conditions such as diabetes, mental health, respiratory disorders, women's health, urology, and much more.
Forwarded from PDFology (Basem Medhat)
كل ما تريد معرفته عن
Bone Marrow Transplant (BMT)
📋 Definition:
* BMT is a potentially curative treatment for various hematologic malignancies and disorders.
* It involves replacing diseased or nonfunctional bone marrow with healthy stem cells, enabling the patient to produce healthy blood cells.
🔬 Applications:
* BMT is considered for a range of conditions, including:
* Acute leukemias
* Lymphomas
* Myeloma
* Aplastic anemia
* Sickle cell disease
🩸Types of BMT:
* Autologous BMT: Utilizes the patient's own stem cells collected prior to conditioning.
* Allogeneic BMT: Employs stem cells from a matched donor, offering a graft-versus-tumor (GVT) effect in malignancies.
🥼 BMT Process:
1. Conditioning Regimen: High-dose chemotherapy and/or radiation therapy eradicate residual malignant cells and immunosuppress the recipient to prepare for engraftment.
2. Stem Cell Collection:
* Autologous: Bone marrow aspiration or peripheral blood stem cell (PBSC) apheresis.
* Allogeneic: PBSC apheresis from a matched donor (HLA-matched sibling or unrelated donor registry).
3. Stem Cell Infusion: Administered intravenously through a central venous catheter.
4. Engraftment: Period where infused stem cells migrate to the bone marrow and begin producing new blood cells.
5. Post-Transplant Care: Close monitoring for engraftment, infections, and graft-versus-host disease (GVHD).
⚕️ Considerations:
* BMT is a complex procedure with significant potential for complications.
* Patient selection requires careful evaluation of disease status, comorbidities, and performance status.
* Supportive care plays a vital role throughout the transplant journey.
🧠 Conclusion:
BMT remains a powerful therapeutic tool offering the potential for cure in various hematologic conditions. However, thorough patient selection, meticulous management, and a multidisciplinary approach are crucial for successful outcomes.
🌐 Reference ➡️ Mayo Clinic
#PDFology
#غزة 🇵🇸
Bone Marrow Transplant (BMT)
📋 Definition:
* BMT is a potentially curative treatment for various hematologic malignancies and disorders.
* It involves replacing diseased or nonfunctional bone marrow with healthy stem cells, enabling the patient to produce healthy blood cells.
🔬 Applications:
* BMT is considered for a range of conditions, including:
* Acute leukemias
* Lymphomas
* Myeloma
* Aplastic anemia
* Sickle cell disease
🩸Types of BMT:
* Autologous BMT: Utilizes the patient's own stem cells collected prior to conditioning.
* Allogeneic BMT: Employs stem cells from a matched donor, offering a graft-versus-tumor (GVT) effect in malignancies.
🥼 BMT Process:
1. Conditioning Regimen: High-dose chemotherapy and/or radiation therapy eradicate residual malignant cells and immunosuppress the recipient to prepare for engraftment.
2. Stem Cell Collection:
* Autologous: Bone marrow aspiration or peripheral blood stem cell (PBSC) apheresis.
* Allogeneic: PBSC apheresis from a matched donor (HLA-matched sibling or unrelated donor registry).
3. Stem Cell Infusion: Administered intravenously through a central venous catheter.
4. Engraftment: Period where infused stem cells migrate to the bone marrow and begin producing new blood cells.
5. Post-Transplant Care: Close monitoring for engraftment, infections, and graft-versus-host disease (GVHD).
⚕️ Considerations:
* BMT is a complex procedure with significant potential for complications.
* Patient selection requires careful evaluation of disease status, comorbidities, and performance status.
* Supportive care plays a vital role throughout the transplant journey.
🧠 Conclusion:
BMT remains a powerful therapeutic tool offering the potential for cure in various hematologic conditions. However, thorough patient selection, meticulous management, and a multidisciplinary approach are crucial for successful outcomes.
🌐 Reference ➡️ Mayo Clinic
#PDFology
#غزة 🇵🇸
Forwarded from PDFology (Basem Medhat)
GLP-1 Comparison.pdf
1019.9 KB
Forwarded from نافع | Nafe3
🪴 الجلسة (3) من جلسات طفرة اليوم الواحد (هذا المنشور)
Forwarded from PDFology (Basem Medhat)
Which is Contraindicated in prinzmetal angina?
Anonymous Quiz
23%
a) Nitroglycerin
17%
b) Nifedipine
40%
c) Atenolol
20%
d) Diltiazem
Forwarded from PDFology (Basem Medhat)
سورة الكهف.pdf
3.7 MB
قال أبي سعيد الخدري رضي الله عنه: قال رسول الله صلى الله عليه وسلم: من قرأ سورة الكهف في يوم الجمعة، أضاء له من النور ما بين الجمعتين. رواه الحاكم والبيهقي وصححه الألباني.
﴿ إِنَّ اللَّهَ وَمَلَائِكَتَهُ يُصَلُّونَ عَلَى النَّبِيِّ ۚ يَا أَيُّهَا الَّذِينَ آمَنُوا صَلُّوا عَلَيْهِ وَسَلِّمُوا تَسْلِيمًا﴾
[ الأحزاب: 56]
﴿ إِنَّ اللَّهَ وَمَلَائِكَتَهُ يُصَلُّونَ عَلَى النَّبِيِّ ۚ يَا أَيُّهَا الَّذِينَ آمَنُوا صَلُّوا عَلَيْهِ وَسَلِّمُوا تَسْلِيمًا﴾
[ الأحزاب: 56]